Evidence-based microbiome analyses.

We partner with physicians, clinics, and researchers interested in high-resolution microbiome analysis and scientific collaboration.

Advanced DNA Shotgun Sequencing

Our Microbiome 360° provides high-resolution shotgun metagenomic sequencing to characterize the gut microbial ecosystem at species and functional level. The generated data can be used in research, exploratory clinical settings, and translational projects investigating microbiome-associated patterns.

Gastrointestinal microbiome research

Characterization of microbial community composition and functional patterns associated with gastrointestinal ecosystem dynamics.

Post-antibiotic microbiome studies

Analysis of microbiome changes following antibiotic exposure and investigation of recovery trajectories and stability.

Metabolic-associated microbiome research

Investigation of microbial patterns and functions associated with metabolic processes and host–microbiome interactions.

Gut-brain axis investigation

Study of microbiome-associated signaling pathways and metabolites involved in gut–brain communication.

Immune–microbiome interaction studies

Characterization of interactions between microbial communities and host immune pathways.

Longitudinal microbiome tracking

Monitoring of microbiome composition over time to analyze temporal dynamics and ecosystem variability.

Status: Regulatory Review Pending

Next-Generation FMT: Non-Invasive Oral Delivery

We have developed a capsule-based Fecal Microbiota Transplantation (FMT) system designed for safe, non-invasive therapeutic use. By transitioning FMT from clinical procedures to oral delivery, we are redefining patient accessibility and ease of treatment.

Regulatory Compliance

Operating under EU Regulation 2024/1938 (SoHO) and following the EDQM Guide to the quality and safety of TISSUES AND CELLS (5th Ed, 2022).
Request Technical Specifications

Partner with Bactera

Our medical liaison team is available to discuss clinical integration, research opportunities, or patient referral protocols. Let's advance microbiome medicine together.

We welcome partnerships with:

· Gastroenterologists
· Infectious disease specialists
· Psychologists / psychiatrists studying the gut-brain axis
· Clinics treating IBD, IBS, CDI, or metabolic disorders
· Research institutions interested in microbiome-based therapies